Lupin gets USFDA approval for diarrhoea drug

NEW DELHI: Drug major Lupin has received approval from the US health regulator to sell a generic version of Vancocin capsules, used in treating diarrhoea, in the American market.

The company has received final approval for its Vancomycin Hydrochloride Capsules in strengths of 125 mg and 250 mg from the US Food and Drugs Administration (FDA) to market a generic version of ANI Pharmaceuticals, Inc’s Vancocin, Lupin Ltd said in a statement.

“Lupin Pharmaceuticals Inc (LPI), the c ..